Quantcast
Home > Quotes > PACB
PACB

Pacific Biosciences of California, Inc. Common Stock (PACB) Quote & Summary Data

$7.36
*  
unch
unch
Get PACB Alerts
*Delayed - data as of Mar. 20, 2019  -  Find a broker to begin trading PACB now
Exchange:NASDAQ
Industry: Capital Goods
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
8
Today's High / Low
$ 7.37 / $ 7.35
Share Volume
569,214
50 Day Avg. Daily Volume
1,523,902
Previous Close
$ 7.36
52 Week High / Low
$ 7.84 / $ 2.02
Market Cap
1,111,065,247
P/E Ratio
NE
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ -0.77
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0.53

Intraday Chart

Shares Traded

Share Volume:
569,214
50 Day Avg. Daily Volume:
1,523,902

P/E Ratio

P/E Ratio:
NE
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ -0.77

Trading Range

The current last sale of $7.36 is 264.36% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 7.37 $ 7.84
 Low: $ 7.35 $ 2.02

Company Description (as filed with the SEC)

On November 1, 2018, we entered into an Agreement and Plan of Merger with Illumina, Inc. ("Illumina") and FC Ops Corp., a wholly-owned subsidiary of Illumina (the "Merger Agreement") pursuant to which Illumina will acquire us for $8.00 per share of our common stock in an all-cash transaction and FC Ops Corp. will be merged with and into us (the "Merger"), with us surviving the Merger and becoming a wholly-owned subsidiary of Illumina. Completion of the transaction is subject to terms and conditions set forth in the Merger Agreement, including expiration or termination of any waiting periods applicable to the consummation of the Merger under the United States Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and clearance under the antitrust laws of certain non-United States jurisdictions. At a Special Meeting of Stockholders held on January 24, 2019, our stockholders, among other things, approved the adoption of the Merger Agreement.  ... More ...  



Risk Grade

Where does PACB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 7.36
Open Date:
Mar. 20, 2019
Close Price:
$ 7.36
Close Date:
Mar. 20, 2019


Consensus Recommendation

Analyst Info